1. The Global Burden of Liver Disease;Younossi ZM;Clin Gastroenterol Hepatol,2023
2. Jeng WJ, Papatheodoridis GV, Lok ASF (2023) Hepat B Lancet 401(10381):1039–1052
3. Liu Z, Li Y, Wang Y, Bai X, Zhang Y (2023) Exosomes in HBV infection. Clin Chim Acta. ; 538:65–69. 4. Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524–537
4. Impact of prior HBV, HAV, and HEV infection on non-alcoholic fatty liver disease;Vassilopoulos S;J Viral Hepat,2023
5. Kumar N, Choudhary NS, Managing HBV (2024) Mar-Apr;14(2):101287 and HCV Infection Pre- and Post-liver Transplant. J Clin Exp Hepatol. 7. Yu X, Liu X, Tan W, Wang X, Zheng X, Huang Y, Chen J, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Shang J, Yan H, Zheng Y, Zhang W, Yin S, Gu W, Deng G, Xiang X, Zhou Y, Hou Y, Zhang Q, Xiong S, Liu J, Chen R, Long L, Jiang X, Luo S, Chen Y, Jiang C, Zhao J, Ji L, Mei X, Li J, Li T, Zheng R, Zhou X, Ren H, Sheng J, Li H, Shi Y. The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution. Hepatol Commun. 2024;8(1): e0354